LunaDNA

LunaDNA

Growth Stage

Uniting for the Common Good

Uniting for the Common Good

Overview

Funding data not publicly available
Platform

Self Managed

Start Date

12/01/2021

Close Date

Not Provided

Min. Goal
$100
Max. Goal
$2,100,000
Min. Investment

$100

Security Type

Equity - Common

Series

Seed

SEC Filing Type

RegA+    Open SEC Filing

Price Per Share

$0.07

Pre-Money Valuation

$25,787

Year Founded

2018

Industry

Healthcare & Pharmaceuticals

Tech Sector

HealthTech

Distribution Model

B2B

Margin

Medium

Capital Intensity

Low

Location

San Diego, California

Business Type

Growth

LunaDNA is raising funds independently through Reg A+ crowdfunding. The company has built the world’s first and largest database of human health, including genomic and phenotypic data. The business makes the database available to researchers with its members’ consent and facilitates new discoveries, new treatments, and greater predictive power of genomic information. LunaDNA has collaborations with companies including Genomelink, Genetic Alliance, San Diego Blood Bank, and The University of Vermont Health Network. Joe Beery, Dawn Barry, and Bob Kain founded LunaDNA in 2018. The current crowdfunding campaign has no minimum target and a maximum target of $2,100,000. The campaign proceeds will be used for operational funding.

Balance Sheet

Cash and Cash Equivalents

$0

Investment Securities

$0

Total Investments

$0

Accounts and Notes Receivable

$0

Loans

$0

Property, Plant and Equipment (PP&E)

$0

Property and Equipment

$0

Total Assets

$51,190

Accounts Payable & Accrued Liabilities

$0

Policy Liabilities and Accruals

$0

Deposits

$0

Long Term Debt

$0

Total Liabilities

$201,334

Total Stockholders' Equity

$-150,144

Total Liabilities and Equity

$51,190

Statement of Comprehensive Income Information

Total Revenues

$39,021

Total Interest Income

$0

Costs & Expenses Applicable to Rev

$63,036

Total Interest Expenses

$0

Depreciation and Amortization

$0

Net Income

$-25,666

Earnings Per Share - Basic

$0.00

Earnings Per Share - Diluted

$0.00

Auditor: Mayer Hoffman McCann P.C.
Financials as of: 12/01/2021
Create a free account today to gain access to KingsCrowd analytics.

Raise History

Offering Name Close Date Platform Valuation/Cap Total Raised Security Type Status Reg Type
LunaDNA 09/27/2023 Self Managed $30,368,392 - Equity - Common Funded RegA+
LunaDNA 09/06/2022 Self Managed $25,787 - Equity - Common Funded RegA+
Create a free account today to gain access to KingsCrowd analytics.

Price per Share History

Note: Share prices shown in earlier rounds may not be indicative of any stock splits.

Valuation History

Revenue History

Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.

Employee History

Funding data not publicly available

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
LunaDNA on Self Managed 2021
Platform: Self Managed
Security Type: Equity - Common
Valuation: $25,787
Price per Share: $0.07

Follow company

Follow LunaDNA on Self Managed 2021
No Public Offering Page

Buy LunaDNA's Deal Report

Warning: according to the close date for this deal, LunaDNA may no longer be accepting investments.

LunaDNA Deal Report

Get KingsCrowd’s comprehensive report on LunaDNA including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether LunaDNA is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the LunaDNA deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge